Focus: Cancer Center Featured Story 2

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 10-May-2021 3:00 PM EDT Released to reporters: 7-May-2021 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-May-2021 3:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Understanding Brain Tumors
Released: 6-May-2021 11:50 AM EDT
Understanding Brain Tumors
Rutgers Cancer Institute of New Jersey

To better understand brain cancer, neuro-oncologist Michael E. Salacz, MD, director of the Neuro-Oncology Program at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some basic information on types of brain tumors, risk factors and treatment options.

Newswise: Study to Examine Exosomes in Ovarian Cancer
Released: 6-May-2021 11:45 AM EDT
Study to Examine Exosomes in Ovarian Cancer
University of Kansas Cancer Center

Researchers have been awarded a $3.1 million grant from the National Institutes of Health to investigate more effective ways to identify ovarian cancer earlier.

Newswise: Heidi E. Conway joins Dana-Farber to lead Human Resources Department
Released: 5-May-2021 9:30 AM EDT
Heidi E. Conway joins Dana-Farber to lead Human Resources Department
Dana-Farber Cancer Institute

New Human Resources and Chief People Officer named at Dana-Farber Cancer Institute.

Released: 4-May-2021 12:50 PM EDT
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Fred Hutchinson Cancer Research Center

SEATTLE — May 4, 2021 — Below are summaries of recent Fred Hutch research findings and other news.If you are covering news at the upcoming American Society of Gene & Cell Therapy, American Society of Clinical Oncology, or other conferences, feel free to reach out to our media team for help sourcing experts:

Newswise: The Greatest Gift for Mom: Health and Wellness
Released: 4-May-2021 9:05 AM EDT
The Greatest Gift for Mom: Health and Wellness
Rutgers Cancer Institute of New Jersey

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

Newswise: CU Cancer Center Technology Gives Kids a Welcome Distraction During Radiation Treatment
Released: 3-May-2021 4:20 PM EDT
CU Cancer Center Technology Gives Kids a Welcome Distraction During Radiation Treatment
University of Colorado Cancer Center

Thirty days of radiation treatments — five days a week, with Saturdays and Sundays off — are difficult for even the toughest of adults. But for a child, they’re even harder to bear. They involve fasting, waking up early, and lying in a dark room alone, without even your parents there for support. But if during treatment you can take a trip to Agrabah to hang out with Aladdin, Jasmine, and the rest of the characters in Disney’s live-action version of “Aladdin,” it makes the sessions a lot easier to bear — not to mention it makes time go by a lot faster. Thanks to a new innovation at the CU Cancer Center, patients like 5-year-old Piper Lardes are able to do just that — watch their favorite show or movie during their treatment to make the whole experience just a little easier. The technology, called Radflix, has a calming effect on parents as well.

Newswise: CU Cancer Center Technology Gives Kids a Welcome Distraction During Radiation Treatment
Released: 3-May-2021 4:20 PM EDT
CU Cancer Center Technology Gives Kids a Welcome Distraction During Radiation Treatment
University of Colorado Cancer Center

Thirty days of radiation treatments — five days a week, with Saturdays and Sundays off — are difficult for even the toughest of adults. But for a child, they’re even harder to bear. They involve fasting, waking up early, and lying in a dark room alone, without even your parents there for support. But if during treatment you can take a trip to Agrabah to hang out with Aladdin, Jasmine, and the rest of the characters in Disney’s live-action version of “Aladdin,” it makes the sessions a lot easier to bear — not to mention it makes time go by a lot faster. Thanks to a new innovation at the CU Cancer Center, patients like 5-year-old Piper Lardes are able to do just that — watch their favorite show or movie during their treatment to make the whole experience just a little easier. The technology, called Radflix, has a calming effect on parents as well.

Newswise: What is Bladder Cancer?
Released: 3-May-2021 10:25 AM EDT
What is Bladder Cancer?
Rutgers Cancer Institute of New Jersey

The bladder, a part of the urinary system, is a hollow organ in the pelvis with the primary function of storing and then eliminating urine that drains into it from the kidney. Cancer of the bladder develops when abnormal cells in the bladder start to grow out of control. Rutgers Cancer Institute expert explains what you need to know.

Newswise: Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplants
30-Apr-2021 3:25 PM EDT
Antiviral T cells safe and effective for treating debilitating complication common after stem cell transplants
University of Texas M. D. Anderson Cancer Center

A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells from healthy donors were safe and effective as an off-the-shelf therapy for BKV-associated hemorrhagic cystitis (BKV-HC), a painful complication common after allogeneic stem cell transplants for patients with leukemia or lymphoma. The study was published today in the Journal of Clinical Oncology.

Newswise: NCCN Releases New Patient Guidelines on Anemia and Neutropenia
30-Apr-2021 11:55 AM EDT
NCCN Releases New Patient Guidelines on Anemia and Neutropenia
National Comprehensive Cancer Network® (NCCN®)

New resource from NCCN helps cancer patients and caregivers recognize and understand blood cell production deficiencies, to better participate in their care planning; available for free at NCCN.org/patientguidelines.

Newswise:Video Embedded massive-negative-impact-of-covid-19-on-cancer-screenings-quantified-in-ku-medical-center-faculty-study-published-in-jama-oncology
VIDEO
Released: 30-Apr-2021 10:55 AM EDT
Massive negative impact of COVID-19 on cancer screenings quantified in KU Medical Center faculty study published in JAMA Oncology
University of Kansas Cancer Center

Nearly 10 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic, according to a study published in JAMA Oncology, a publication of the American Medical Association.

Released: 29-Apr-2021 9:00 AM EDT
MD Anderson advances data collaboration through technology agreement with Syntropy
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced efforts to advance its capabilities to seamlessly connect basic science, translational and clinical research data for the benefit of patients through a technology collaboration with Syntropy and the Foundry platform.

Released: 28-Apr-2021 1:35 PM EDT
Male bladder cancer vulnerability could lead to a new treatment approach
UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein specific to men - may destroy cancer cells. Focusing on this male protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.

Newswise:Video Embedded tanning-beds-and-skin-cancer-heeding-the-call-to-action
VIDEO
Released: 28-Apr-2021 12:50 PM EDT
Tanning Beds and Skin Cancer: Heeding the Call to Action
Rutgers Cancer Institute of New Jersey

Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning. Researchers at Rutgers Cancer Institute of New Jersey recently addressed the importance of increasing efforts to limit indoor tanning among minors in a viewpoint paper published in the April 28 2021 online edition of JAMA Dermatology.

Newswise: PsychLight Sensor to Enable Discovery of New Psychiatric Drugs
Released: 28-Apr-2021 12:35 PM EDT
PsychLight Sensor to Enable Discovery of New Psychiatric Drugs
UC Davis Health

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

Newswise: Ludwig Cancer Research Study Shows Pancreatic Cancer Cells Hit Reverse to Advance in Malignancy
Released: 28-Apr-2021 9:15 AM EDT
Ludwig Cancer Research Study Shows Pancreatic Cancer Cells Hit Reverse to Advance in Malignancy
Ludwig Cancer Research

A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert—or “de-differentiate”—to a progenitor, or immature, state of cellular development to spawn highly aggressive tumors that are capable of metastasis to the liver and lymph nodes.

Newswise: Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences
Released: 27-Apr-2021 12:25 PM EDT
Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Deputy Director, Chief Scientific Officer, and Associate Director for Basic Research Eileen White, PhD, has been elected to the National Academy of Sciences (NAS). She is among 120 members elected this year in recognition of their distinguished and continuing achievements in original research.

Newswise: $9 Million Contract from National Cancer Institute Awarded for NJ State Cancer Registry
Released: 27-Apr-2021 8:45 AM EDT
$9 Million Contract from National Cancer Institute Awarded for NJ State Cancer Registry
Rutgers Cancer Institute of New Jersey

The New Jersey State Cancer Registry (NJSCR), under the direction of the State Department of Health in partnership with Rutgers Cancer Institute of New Jersey, has been awarded a seven-year, $9,085,109 contract (75N91021D00009) from the National Cancer Institute (NCI) to support core infrastructure and research activities as part of the Surveillance, Epidemiology, and End Results (SEER) Program, the most authoritative source of information on cancer incidence and survival in the United States. The funding will support ongoing cancer surveillance activities at the NJSCR, as well as support enhancements to New Jersey’s electronic reporting systems such as electronic pathology and medical claims data transmissions.

Newswise:Video Embedded new-rapid-covid-19-test-the-result-of-university-industry-partnership
VIDEO
Released: 26-Apr-2021 3:25 PM EDT
New rapid COVID-19 test the result of university-industry partnership
UC Davis Health

A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a 20-minute COVID-19 test. The method pairs a mass spectrometer with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. A recent study published in Nature Scientific Reports shows the test to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests.

26-Apr-2021 1:45 PM EDT
For young patients with breast cancer, fertility concerns influence endocrine therapy decisions, study finds
Dana-Farber Cancer Institute

Concerns about fertility often influence how young women with breast cancer approach treatment decisions and are a reason for forgoing or delaying hormone-blocking therapy, a new study by Dana-Farber Cancer Institute investigators shows.

Released: 23-Apr-2021 2:05 PM EDT
Is raising the sales age of tobacco reducing youth smoking?
UC Davis Comprehensive Cancer Center

A new study, conducted by three UC Davis Comprehensive Cancer Center researchers, studies young adult smoking trends three years after the start of California’s law raising the sales age of tobacco to 21.

Newswise: Dana-Farber Cancer Institute faculty recognized as 2021 ASCO leaders in cancer care
Released: 23-Apr-2021 8:45 AM EDT
Dana-Farber Cancer Institute faculty recognized as 2021 ASCO leaders in cancer care
Dana-Farber Cancer Institute

The American Society of Clinical Oncology (ASCO) recognized two Dana-Farber Cancer Institute researchers as winners of ASCO's Special Awards, the Society’s highest honors. The recipients of these awards have worked to transform cancer care around the world.

Newswise: Carol Fabian Recognized As Fellow of the American Society of Clinical Oncology
Released: 23-Apr-2021 8:40 AM EDT
Carol Fabian Recognized As Fellow of the American Society of Clinical Oncology
University of Kansas Cancer Center

Carol Fabian, MD, FASCO, a nationally recognized medical oncologist and breast cancer researcher, has been named a Fellow of the American Society of Clinical Oncology (FASCO).

Newswise: Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
Released: 22-Apr-2021 4:30 PM EDT
Yale Cancer Center Study Shows Cognitive Impairment for Survivors of Many Pediatric Cancers
Yale Cancer Center

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income. The results were published online today in the Journal of Clinical Oncology (JCO).

Newswise: Roswell Park, Wilmot Cancer Institute Collaborate on First Large Study of Immunotherapy in Black Cancer Patients
Released: 20-Apr-2021 3:45 PM EDT
Roswell Park, Wilmot Cancer Institute Collaborate on First Large Study of Immunotherapy in Black Cancer Patients
Roswell Park Comprehensive Cancer Center

A new collaboration between two Western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment, and seeks to improve the safety and effectiveness of these newer drugs in diverse populations.

Newswise: ‘Information Theory’ Recruited to Help Scientists Find Cancer Genes
Released: 20-Apr-2021 1:00 PM EDT
‘Information Theory’ Recruited to Help Scientists Find Cancer Genes
Johns Hopkins Medicine

Using a widely known field of mathematics designed mainly to study how digital and other forms of information are measured, stored and shared, scientists at Johns Hopkins Medicine and Johns Hopkins Kimmel Cancer Center say they have uncovered a likely key genetic culprit in the development of acute lymphoblastic leukemia (ALL).

Released: 20-Apr-2021 8:05 AM EDT
Dana-Farber nurses present research at 2021 Oncology Nursing Society Congress
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers are presenting key studies at the 46th Annual Oncology Nursing Society (ONS) Congress. The presentations focus on the effects of the COVID-19 crisis, the need for diversity, equity and inclusion in oncology nursing as well as the critical role oncology nurse navigators play in a patient’s treatment plan.

Newswise: Exploring a New Therapeutic Strategy for T-cell Acute Lymphoblastic Leukemia
Released: 20-Apr-2021 6:05 AM EDT
Exploring a New Therapeutic Strategy for T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey, recently discovered that a mitochondrial uncoupling drug is toxic against leukemic cells, revealing a potential therapeutic strategy against T-ALL.

Newswise: Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
Released: 19-Apr-2021 9:00 AM EDT
Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
Yale Cancer Center

In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumor DNA damage response.

Newswise: Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
19-Apr-2021 8:00 AM EDT
Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
Yale Cancer Center

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).

Newswise: University of Colorado Inter-campus Collaboration Wins R01 Award for Salivary Gland Cancer
Released: 16-Apr-2021 3:15 PM EDT
University of Colorado Inter-campus Collaboration Wins R01 Award for Salivary Gland Cancer
University of Colorado Cancer Center

Two University of Colorado Cancer Center researchers have received a five-year R01 Award for $497,893 per year from the National Institutes of Health (NIH) to study a potential new drug treatment for salivary gland cancer. The award is part of an inter-campus collaboration between Antonio Jimeno, MD, PhD, co-leader of the Developmental Therapeutics Program, and Tin Tin Su, PhD, co-leader of the Molecular and Cellular Oncology Program.

Newswise: NCCN Foundation Announces Awards for Rising Cancer Research Leaders
Released: 15-Apr-2021 8:35 AM EDT
NCCN Foundation Announces Awards for Rising Cancer Research Leaders
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network announces recipients of 2021 NCCN Foundation Young Investigator Awards; projects from early-career investigators to advance research in cancer prevention, racial disparities in screening, immunotherapy, new insights in radiotherapy, and CAR T-cell therapy.

Released: 14-Apr-2021 9:00 AM EDT
MD Anderson and Boehringer Ingelheim expand collaboration to accelerate development of KRAS and TRAILR2 compounds in lung cancer
University of Texas M. D. Anderson Cancer Center

MD Anderson and Boehringer Ingelheim have expanded their joint Virtual Research and Development Center to accelerate the development of new targeted therapies against KRAS and TRAILR2 in lung cancer.

Newswise: NCCN Announces Projects to Study Oral Decitabine and Cedazuridine in Collaboration with Taiho Oncology
Released: 14-Apr-2021 8:35 AM EDT
NCCN Announces Projects to Study Oral Decitabine and Cedazuridine in Collaboration with Taiho Oncology
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced that three projects have been selected to study oral decitabine (35 mg) and cedazuridine (100 mg).

Newswise: Rutgers Cancer Institute of New Jersey Awarded $1.3M for Cancer Metabolism and Growth Research Program
Released: 14-Apr-2021 8:05 AM EDT
Rutgers Cancer Institute of New Jersey Awarded $1.3M for Cancer Metabolism and Growth Research Program
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute has received a $1.3 million, five-year grant from the National Cancer Institute to support the Cancer Metabolism and Growth and Tumor Host Interactions Training Program which will provide postdoctoral candidates the highest quality training and research experience.

Newswise: JNCCN Study: Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer
Released: 13-Apr-2021 8:35 AM EDT
JNCCN Study: Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer
National Comprehensive Cancer Network® (NCCN®)

International study finds 4% of patients with metastatic renal cell carcinoma developed asymptomatic brain metastases, which correlated to poorer outcomes.

Newswise: Ludwig Cancer Research Opens New Branch 
Dedicated to Cancer Metabolism at Princeton University
Released: 13-Apr-2021 8:30 AM EDT
Ludwig Cancer Research Opens New Branch Dedicated to Cancer Metabolism at Princeton University
Ludwig Cancer Research

Ludwig Cancer Research is proud to announce on its 50th anniversary the launch of the newest Branch of the Ludwig Institute for Cancer Research.

Newswise: Increase your Awareness of Head and Neck Cancers
Released: 12-Apr-2021 10:05 AM EDT
Increase your Awareness of Head and Neck Cancers
Rutgers Cancer Institute of New Jersey

Accounting for approximately four percent of all cancers nationwide according to the National Cancer Institute, head and neck cancer is the term used to describe a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses and mouth. Even though these cancers are not as prevalent as others, everyone should be aware of risk factors and symptoms.

Newswise: Huntsman Cancer Institute Research Shows Melanoma Incidence and Mortality Higher in Utah Compared to Rest of U.S.
Released: 12-Apr-2021 9:00 AM EDT
Huntsman Cancer Institute Research Shows Melanoma Incidence and Mortality Higher in Utah Compared to Rest of U.S.
Huntsman Cancer Institute at the University of Utah

A letter published today by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the rest of the United States during the period from 1975 to 2013. Melanoma death rates have been decreasing in recent years both in Utah and the United States, a trend likely attributable to new, more effective treatments, like immunotherapy. However, melanoma remains the deadliest type of skin cancer, and the incidence of melanoma diagnoses in Utahns is higher than in any other state.

Newswise: Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
Released: 12-Apr-2021 9:00 AM EDT
Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
University of Texas M. D. Anderson Cancer Center

Preclinical research identifies CREB1 as new therapeutic target downstream of frequently mutated genes

Newswise: MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
Released: 12-Apr-2021 9:00 AM EDT
MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
University of Texas M. D. Anderson Cancer Center

FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and thyroid cancers (Abstract CT011); Combining dabrafenib and trametinib to treat BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG) shows significant antitumor activity; Therapeutics Discovery researchers identify key biomarker for metabolic inhibitor

Released: 12-Apr-2021 9:00 AM EDT
Karen E. Knudsen to Step Down as President of Association of American Cancer Institutes
Association of American Cancer Institutes (AACI)

Association of American Institutes (AACI) President Karen E. Knudsen, MBA, PhD, announced today that she is resigning from Sidney Kimmel Cancer Center (SKCC) at Jefferson Health in Philadelphia. She will step down as AACI president and begin a new role as chief executive officer of the American Cancer Society (ACS) on June 1.

Released: 12-Apr-2021 9:00 AM EDT
Seeking Therapeutic Strategies against Non-Small Cell Lung Cancer with Autophagy
Rutgers Cancer Institute of New Jersey

Autophagy is a process where a cell eats itself to maintain cellular metabolism during metabolic stress.

Released: 10-Apr-2021 8:30 AM EDT
MSK Medical Oncologist Matthew Matasar Featured in the 2021 AACR Annual Meeting Week 1 Press Program
Memorial Sloan Kettering Cancer Center

Research Presented Found that Copanlisib-Rituximab Combination Reduced Lymphoma Progression or Death by Nearly Half in CHRONOS-3 Trial

Released: 8-Apr-2021 8:05 AM EDT
Moffitt Investigators Identify Sting Gene Methylation That Allows Melanoma to Evade the Immune System
Moffitt Cancer Center

A dysfunctional immune system significantly contributes to the development of cancer. Several therapeutic strategies to activate the immune system to target cancer cells have been approved to treat different types of cancer, including melanoma.

Released: 8-Apr-2021 8:05 AM EDT
Addressing Cancer Disparities: Challenges and Creating Change
Rutgers Cancer Institute of New Jersey

Racial and ethnic minority groups, low income, underinsured, or uninsured individuals as well as those living in rural areas, often face greater obstacles when it comes to preventing, treating and surviving cancer.


Showing results

150 of 2355

close
5.49069